- Latest week
- 10 Jul 2026
- Close
- 1.200500
- Fair value
- 1.043814
- Next-week expectancy
- Undecided 53.29%
PHARM Chart Pack
Pharming Group N.V.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, PHARM fell 15.52%, moving from 1.42 to 1.20. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -16.36 and has softened across the 12-week window. Market Dynamics is -1.07 on the latest week. Next-week expectancy is undecided at 53.29% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1.20
- 12-Week Change
- -15.52%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 53.29%
- Signal Weeks
- 2 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -16.36
- Market Dynamics
- -1.07
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1.20
- 12-Week Change
- -15.52%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 53.29%
- Signal Weeks
- 2 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -16.36
- Market Dynamics
- -1.07
Over the latest 12 completed weeks ending 2026-07-10, PHARM fell 15.52%, moving from 1.42 to 1.20. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -16.36 and has softened across the 12-week window. Market Dynamics is -1.07 on the latest week. Next-week expectancy is undecided at 53.29% based on similar historical setup states.
Industry Peers
Netherlands equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| VVY Vivoryon Therapeutics N.V. | AMS | 10 Jul 2026 | 1.10 | 1.50 | 1.09 | 1.40 | 27.27% |